Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123860632 | 12386063 | 2 | F | 20160803 | 20160519 | 20160809 | EXP | PE-PFIZER INC-2016261752 | PFIZER | 69.00 | YR | F | Y | 0.00000 | 20160809 | MD | PE | PE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123860632 | 12386063 | 1 | PS | EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | 1 | 150 MG, DAILY | 20699 | 150 | MG | PROLONGED-RELEASE CAPSULE | ||||||||
| 123860632 | 12386063 | 2 | SS | EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | 1 | 75 MG, DAILY AT NIGHTS | 20699 | 75 | MG | PROLONGED-RELEASE CAPSULE | ||||||||
| 123860632 | 12386063 | 3 | SS | EFFEXOR XR | VENLAFAXINE HYDROCHLORIDE | 1 | 2 DF (75MG), DAILY WHEN FEELS ANXIOUS AND DESPERATE | 20699 | 2 | DF | PROLONGED-RELEASE CAPSULE |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123860632 | 12386063 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123860632 | 12386063 | Anxiety | |
| 123860632 | 12386063 | Feeling of despair | |
| 123860632 | 12386063 | Intentional product use issue | |
| 123860632 | 12386063 | Neoplasm malignant |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |